Drug recall · February 14, 2018
VELCADE recall
Why: Defective Container: Confirmed reports of loose vial crimps.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
VELCADE (bortezomib) for injection, 3.5 mg/vial, Reconstitution Information, SUBCUTANEOUS INJECTION ONLY add 1.4 mL 0.9% Sodium Chloride to make 2.5 mg/ mL final concentration, INTRAVENOUS INJECTION ONLY add 3.5 mL Sodium Chloride to 1 mg/mL final concentration, Rx Only, Distributed by MILLENNIUM Pharmaceuticals, Inc., Cambridge, MA 02139-4234, NDC 63020-0049-01
- Lots / codes
Lot Numbers # 224161, 224546 and 224547; Exp. 12/19
- Quantity
- 154,372 vials
- Company
- Millennium Pharmaceuticals Inc., Cambridge, MA
- Distribution
- Distributed nationwide. They estimate 4% of the product may be recovered.
- Initiated
- January 30, 2018 · Voluntary: Firm initiated
- Classified
- February 14, 2018
- Reported
- February 14, 2018
- Ended
- December 12, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bortezomib
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.